Literature DB >> 9295025

G1 arrest and high expression of cyclin kinase and apoptosis inhibitors in accumulated activated/memory phenotype CD4+ cells of older lupus mice.

H Sabzevari1, S Propp, D H Kono, A N Theofilopoulos.   

Abstract

A general characteristic of lupus-prone mice (and humans) is the expedited accumulation of large numbers of presumably self-reactive activated/memory phenotype T cells. The mechanism by which these cells escape apoptosis has not been defined. We used activated/memory phenotype CD4+ cells from male BXSB mice with early-life severe lupus-like disease to investigate cell cycle status and apoptosis susceptibility, and to determine the role of corresponding genes in survival of these cells. In vitro acridine orange staining indicated that most of the rapidly accumulating memory phenotype CD4+ T cells of 4-month-old male BXSB mice are G1 arrested. Long-term bromodeoxyuridine in vivo labeling also showed that with advanced age, there was a shift of the CD4+ CD44(hi) male cells from predominantly cycling to predominantly noncycling. Moreover, the CD4+ CD44(hi) cells of older males were refractory to anti-CD3-induced proliferation and apoptosis. Using a multiprobe RNase protection assay encompassing riboprobe panels for cell cycle and apoptosis-related genes, we found that these cells exhibited high expression of certain members of the Ink4 (p18Ink4C) and Cip/Kip (p21Cip1) families of cyclin kinase inhibitors as well as of the apoptosis-inhibiting Bcl-xL gene. Western blot analysis confirmed increased levels of Bcl-xL and p21Cip1, and also identified increases in another cyclin kinase inhibitor, p27Kip1. We propose that in autoimmunity, self-reactive CD4+ cells are subjected to successive rounds of activation/division that eventually lead to a build-up in cyclin-dependent kinase inhibitors. Once high levels of such inhibitors are reached, they cause refractoriness to further activation, impaired cell cycle entry and resistance to apoptosis, a situation akin to replicative senescence.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9295025     DOI: 10.1002/eji.1830270813

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  14 in total

Review 1.  Tumour necrosis factor and other cytokines in murine lupus.

Authors:  A N Theofilopoulos; B R Lawson
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

Review 2.  T cell homeostasis and systemic autoimmunity.

Authors:  A N Theofilopoulos; W Dummer; D H Kono
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

Review 3.  Genetic studies in systemic autoimmunity and aging.

Authors:  D H Kono; A N Theofilopoulos
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

4.  G1/S cell cycle arrest provoked in human T cells by antibody to CD26.

Authors:  Kei Ohnuma; Tomonori Ishii; Satoshi Iwata; Osamu Hosono; Hiroshi Kawasaki; Masahiko Uchiyama; Hirotoshi Tanaka; Tadanori Yamochi; Nam H Dang; Chikao Morimoto
Journal:  Immunology       Date:  2002-11       Impact factor: 7.397

5.  A small-molecule macrophage migration inhibitory factor antagonist protects against glomerulonephritis in lupus-prone NZB/NZW F1 and MRL/lpr mice.

Authors:  Lin Leng; Liang Chen; Juan Fan; Dorothee Greven; Alvaro Arjona; Xin Du; David Austin; Michael Kashgarian; Zhinan Yin; Xiao R Huang; Hui Y Lan; Elias Lolis; David Nikolic-Paterson; Richard Bucala
Journal:  J Immunol       Date:  2010-11-24       Impact factor: 5.422

6.  Intercellular adhesion molecule-1 inhibits interleukin 4 production by naive T cells.

Authors:  C R Luksch; O Winqvist; M E Ozaki; L Karlsson; M R Jackson; P A Peterson; S R Webb
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

7.  Accelerated pathological and clinical nephritis in systemic lupus erythematosus-prone New Zealand Mixed 2328 mice doubly deficient in TNF receptor 1 and TNF receptor 2 via a Th17-associated pathway.

Authors:  Noam Jacob; Haitao Yang; Luminita Pricop; Yi Liu; Xiaoni Gao; Song Guo Zheng; Juhua Wang; Hua-Xin Gao; Chaim Putterman; Michael N Koss; William Stohl; Chaim O Jacob
Journal:  J Immunol       Date:  2009-02-15       Impact factor: 5.422

8.  Interleukin-6 is responsible for aberrant B-cell receptor-mediated regulation of RAG expression in systemic lupus erythematosus.

Authors:  Sophie Hillion; Soizic Garaud; Valérie Devauchelle; Anne Bordron; Christian Berthou; Pierre Youinou; Christophe Jamin
Journal:  Immunology       Date:  2007-07-03       Impact factor: 7.397

9.  Xenobiotic acceleration of idiopathic systemic autoimmunity in lupus-prone bxsb mice.

Authors:  K M Pollard; D L Pearson; P Hultman; T N Deane; U Lindh; D H Kono
Journal:  Environ Health Perspect       Date:  2001-01       Impact factor: 9.031

Review 10.  T Cell Homeostatic Proliferation Promotes a Redox State That Drives Metabolic and Epigenetic Upregulation of Inflammatory Pathways in Lupus.

Authors:  Ralph C Budd; Christopher D Scharer; Ramiro Barrantes-Reynolds; Scott Legunn; Karen A Fortner
Journal:  Antioxid Redox Signal       Date:  2021-11-09       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.